Zhejiang Chimin Pharm Co Ltd

SHG:603222 China Medical Instruments & Supplies
Market Cap
$632.64 Million
CN¥4.64 Billion CNY
Market Cap Rank
#12084 Global
#2949 in China
Share Price
CN¥8.84
Change (1 day)
+0.00%
52-Week Range
CN¥5.68 - CN¥14.06
All Time High
CN¥57.73
About

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, in… Read more

Zhejiang Chimin Pharm Co Ltd - Asset Resilience Ratio

Latest as of September 2024: 4.12%

Zhejiang Chimin Pharm Co Ltd (603222) has an Asset Resilience Ratio of 4.12% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥100.00 Million
Cash + Short-term Investments
Total Assets
CN¥2.43 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2018–2023)

This chart shows how Zhejiang Chimin Pharm Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Chimin Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥100.00 Million 4.12%
Total Liquid Assets CN¥100.00 Million 4.12%

Asset Resilience Insights

  • Limited Liquidity: Zhejiang Chimin Pharm Co Ltd maintains only 4.12% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Zhejiang Chimin Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Chimin Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Beijing Centergate Technologies Holding Co Ltd
SHE:000931
Medical Instruments & Supplies 0.06%
Blue Sail Medical Co Ltd
SHE:002382
Medical Instruments & Supplies 5.12%
Andon Health Co Ltd
SHE:002432
Medical Instruments & Supplies 35.75%
Allmed Medical Products Co Ltd Class A
SHE:002950
Medical Instruments & Supplies 3.78%
Inix Technologies Holdings Bhd
KLSE:0094
Medical Instruments & Supplies 0.06%
Focus Point Holdings Bhd
KLSE:0157
Medical Instruments & Supplies 2.30%
Careplus Group Bhd
KLSE:0163
Medical Instruments & Supplies 4.91%
LKL International Bhd
KLSE:0182
Medical Instruments & Supplies 0.38%

Annual Asset Resilience Ratio for Zhejiang Chimin Pharm Co Ltd (2018–2023)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Chimin Pharm Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 4.44% CN¥110.00 Million CN¥2.48 Billion +1.23pp
2021-12-31 3.20% CN¥77.68 Million CN¥2.43 Billion -2.41pp
2020-12-31 5.61% CN¥128.59 Million CN¥2.29 Billion -0.84pp
2019-12-31 6.45% CN¥134.41 Million CN¥2.08 Billion +0.36pp
2018-12-31 6.09% CN¥129.47 Million CN¥2.12 Billion --
pp = percentage points